Evidence map›Paper›PMID 29610308›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Increased autophagy blocks HER2-mediated breast tumorigenesis.

Silvia Vega-Rubín-de-Celis, Zhongju Zou, Álvaro F Fernández, Bo Ci, Min Kim, Guanghua Xiao, Yang Xie, Beth Levine

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 138 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. The Biological Role and Clinical Significance of BECLIN-1 in Cancer.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Metabolic hallmarks of trastuzumab resistance.Expert opinion on therapeutic targets · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Silvia Vega-Rubín-de-CelisCenter for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Zhongju ZouCenter for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Álvaro F FernándezCenter for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Bo CiDepartment of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Min KimDepartment of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Guanghua XiaoDepartment of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Yang XieDepartment of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Beth LevineCenter for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390; beth.levine@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · USHoward Hughes Medical Institute · USSouthwestern Medical Center · US

Funding

Beclin 1-Bcl-2 Interactions: Effects on AutophagyR01CA109618 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI LEVINE, BETH C · 2004 to 2014
$3.1M
Integrative Analysis to Identify Therapeutic Targets for Lung CancerR01CA172211 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2013 to 2017
$1.6M
Integrative Analysis to Identify Regulation Targets of RNA-Binding ProteinsR01GM115473 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2016 to 2019
$1.3M
NCI NIH HHS R01 CA109618NCI NIH HHS R01 CA172211NIGMS NIH HHS R01 GM115473
6 · The paper itself

Abstract

Allelic loss of the autophagy gene,

Indexed as

AutophagyAmino Acid SubstitutionAnimalsAntineoplastic AgentsBeclin-1Breast NeoplasmsCell Line, TumorErb-b2 Receptor Tyrosine KinasesFemaleGene Knock-In TechniquesHumansLapatinibMiceMice, Inbred C57BLMice, TransgenicMolecular Targeted TherapyAntineoplastic AgentsBeclin-1BECN1 protein, humanBecn1 protein, mouseERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesLapatinibNeoplasm ProteinsPeptide FragmentsProtein Kinase InhibitorsQuinazolinesautophagyBeclin 1breast cancerHER2

Identifiers

PMID29610308
PMCPMC5910832
OpenAlexW2795546909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.